• Network Pharmacology Reveals Anti-Glioma Actions of Chrysant

  2026-06-10

  This study provides a comprehensive analysis of Chrysanthemum indicum L. extract’s (CIE) anti-glioma effects, integrating network pharmacology, molecular docking, and experimental validation in cell and animal models. The findings highlight key molecular targets, notably the androgen receptor, and demonstrate CIE’s capacity to inhibit glioma cell proliferation and promote apoptosis—offering promising directions for future therapeutic strategies.

• Escitalopram: Mechanisms and Strategy for Translational Succ

  2026-06-10

  Explore the strategic use of Escitalopram (Lexapro) in translational research, blending mechanistic insights with evidence-backed guidance for optimizing antidepressant and anxiolytic studies. This article dissects serotonin transporter inhibition, evaluates recent augmentation trials, and delivers actionable protocol strategies with a focus on APExBIO’s high-purity offering.

• PAD4-IN-2 TFA: Tumor-Targeted PAD4 Inhibition via m-PBA Modi

  2026-06-09

  PAD4-IN-2 TFA (Compound 5i TFA) is a highly selective PAD4 inhibitor leveraging meta-phenylboronic acid modification for tumor-specific delivery. The compound inhibits histone H3 citrullination and NET formation, suppresses tumor growth and metastasis, and modulates the tumor immune microenvironment with minimal toxicity, as demonstrated in recent peer-reviewed studies.

• Tubastatin A Inhibits Pyroptosis and Necroptosis After Cardi

  2026-06-09

  The referenced study demonstrates that Tubastatin A, a selective HDAC6 inhibitor, effectively reduces post-resuscitation myocardial injury in a porcine cardiac arrest model by inhibiting GSDME-mediated pyroptosis and MLKL-mediated necroptosis. These findings provide mechanistic insights into HDAC6 inhibition for cardiac protection and inform future translational research.

• Angiotensin II–HIF-1α Axis Drives Radioresistance in NPC

  2026-06-08

  This study reveals that local angiotensin II enhances radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis through the HIF-1α-HILPDA pathway. Targeting the angiotensin II–HIF-1α–HILPDA axis, alongside ferroptosis induction, offers a promising strategy to increase NPC radiosensitivity and improve clinical outcomes.

• Probenecid (B2014): Reliable Solutions for Cell-Based Assays

  2026-06-08

  This evidence-based guide explores how Probenecid (SKU B2014) addresses common laboratory challenges in cell viability, cytotoxicity, and multidrug resistance assays. By analyzing real-world scenarios, we highlight the biochemical and workflow advantages of Probenecid, supported by quantitative data and literature, to help researchers achieve reproducible, high-integrity results.

• Annexin V-APC/7-AAD Apoptosis Kit: Advanced Detection in Leu

  2026-06-07

  The Annexin V-APC/7-AAD Apoptosis Kit delivers rapid, dual-parameter quantification of apoptosis and necrosis, streamlining data-rich cell death analysis in complex disease models. Its single-step workflow and robust phosphatidylserine specificity offer a decisive edge for researchers studying therapy response and cell fate, particularly in aggressive hematologic cancers.

• Açaí Extracts: Cytotoxicity and Enzyme Induction in Hepatocy

  2026-06-06

  This study systematically evaluated the cytotoxic and enzyme/transporter induction potential of various açaí (Euterpe oleracea) extracts in human hepatocytes. While certain extracts reduced cell viability in a dose- and time-dependent manner, all extracts showed minimal risk for inducing key drug-metabolizing enzymes or transporters, informing risk assessment for botanical-drug interactions.

• Tetracycline: Advanced Workflows for Ribosomal and ER Stress

  2026-06-05

  Tetracycline, a broad-spectrum polyketide antibiotic from APExBIO, empowers researchers to dissect ribosomal function and ER stress responses with precision. This guide delivers stepwise protocols, troubleshooting strategies, and highlights from recent mechanistic studies, positioning Tetracycline as an indispensable tool for both antibiotic selection and disease modeling in molecular biology.

• PP 1: Precision Src Family Tyrosine Kinase Inhibition in Can

  2026-06-05

  PP 1 stands out as a highly selective Src family tyrosine kinase inhibitor, empowering researchers to interrogate cancer and immune signaling with nanomolar precision. This article delivers workflow-optimized protocols, troubleshooting strategies, and translational insights for leveraging PP 1 in advanced oncology models, with practical guidance drawn from recent prostate cancer research.

• Streptavidin – Cy5: Illuminating Translational Oncology Work

  2026-06-04

  This thought-leadership article explores how Streptavidin – Cy5 enables next-generation biotin detection in oncology research, bridging mechanistic insight with strategic workflow guidance for translational scientists. Integrating recent breast cancer findings and competitive landscape analysis, we chart a new course for sensitive, reproducible, and clinically relevant detection in IHC, immunofluorescence, and flow cytometry.

• (+)-Bicuculline: Technical Protocols for GABAA Receptor Anta

  2026-06-04

  (+)-Bicuculline is a competitive GABAA receptor antagonist optimized for dissecting inhibitory neurotransmission in neuroscience research. It is not intended for any diagnostic, clinical, or therapeutic use. Proper handling, solubility management, and workflow discipline are essential for reliable outcomes in synaptic signaling and memory impairment studies.

• Calnexin Dependence and CFTR Corrector Response in CF Varian

  2026-06-03

  Tedman et al. systematically profiled the calnexin dependence of over 200 clinical CFTR variants, uncovering how this chaperone modulates both baseline expression and pharmacological rescue, particularly in the context of F508del and related mutations. Their findings provide mechanistic insight for variant-specific cystic fibrosis transmembrane conductance regulator modulation and inform precision approaches in cystic fibrosis research.

• Ceramide-Driven Lipid Remodeling in Fish Nodavirus Infection

  2026-06-03

  This study uncovers how red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism to promote viral replication in marine fish cells. By leveraging global lipidomics and functional assays, the authors reveal that ceramide accumulation is a key driver of pro-viral autophagy, highlighting new antiviral targets and advancing the mechanistic understanding of host-virus lipid interactions.

• Universal nPEC Method for Dual-Loaded Liposome Encapsulation

  2026-06-02

  This study introduces a nanoparticle exclusion chromatography (nPEC) method as a robust, universally applicable approach for accurately determining encapsulation efficiency in dual-loaded liposomes. Its validated performance across diverse drug pairs, including oleanolic acid, advances the reliability of combination drug delivery research.

450 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page